Endoscopic treatment of acute necrotizing pancreatitis - Influence of timing of intervention on treatment success, complications and mortality - a monocentric retrospective analysis

• Conditions: K85; Acute pancreatitis

• Registration Number: DRKS00032583
• Lead Sponsor: Klinikum Oldenburg AöR

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-09-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

all consecutive patients (01/2002-06-2021) who underwent endoscopic transluminal debridement for acute necrotising pancreatitis.

Exclusion Criteria

Patients < 18 years
Endoscopic treatment without debridement

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Combined primary endpoint of endoscopic treatment success without pancreatitis-associated mortality, without surgery, without major complications

Secondary Outcome Measures

Name	Time	Method
pancreatitis-associated mortality <br>28-day mortality after index procedure<br>major bleeding requiring surgery<br>perforation requiring surgery<br>minor bleeding requiring endoscopic treatment<br>stent dislocation<br>Surgery for therapy-refractory necrosis